机译:一项随机,安慰剂对照,双盲,3期临床试验,评估anagliptin在2型糖尿病无药物患者中的疗效和安全性
Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 137-701, Korea;
Diabetes Center, Eulji General Hospital, Eulji University School of Medicine, Seoul, 139-872, Korea;
Diabetes Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 110-746, Korea;
Department of Internal Medicine, Yonsei University, Wonju College of Medicine, Wonju, 220-701, Korea;
Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, 110-744, Korea;
Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, 463-707, Korea;
Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 150-713, Korea;
Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, 134-701, Korea;
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710, Korea;
Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, 120-750, South Korea;
Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Korea University, Seoul, 136-701, Korea;
Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, 602- 739, Korea;
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 120-749, Korea;
Department of Internal Medicine, Busan Paik Hospital, College of Medicine, Paik Institute for Clinical Research, Inje University, Busan, 614- 735, Korea;
Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, 442-723, Korea;
Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Aging and Metabolism, Kyungpook National University School of Medicine, Daegu, 700-721, Korea;
Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, 420-717, Korea;
Division of Endocrinology and Metabolism, Department of Internal Medicine, Chung-Ang University, Seoul, 156-755, Korea;
Division of Endocrinology and Metabolism, Gachon University, Gil Medical Center, Incheon, 405-760, Korea;
Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, 561-712, Korea;
Division of Endocrinology and Metabolism, Department of Internal Medicine Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, # 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea;
DPP-4 inhibitor; Glycemic control; Type 2 diabetes;
机译:一项随机,安慰剂对照,双盲,3期临床试验,评估anagliptin在未接受过药物治疗的2型糖尿病患者中的疗效和安全性
机译:一项多中心,跨国,随机,安慰剂对照,双盲,3期临床试验,评估吉西格列汀(LC15-0444)在2型糖尿病患者中的疗效和安全性
机译:一项多中心,随机,安慰剂对照,双盲II期临床试验,评估LC 15-0444对2型糖尿病患者的最佳剂量,疗效和安全性
机译:一种双盲随机安慰剂对照临床试验,探讨硫霉素在野生植物中猪增殖肠病(PPE)和猪结肠螺旋肌肤症(PCS)的疗效
机译:鱼油(二十碳五烯酸和二十二碳六烯酸)对急性肺损伤患者的肺和全身炎症的II期,随机,双盲,安慰剂对照试验。
机译:一项随机双盲安慰剂对照的II期临床试验旨在研究口服DA-1229在饮食和运动对血糖控制不足的2型糖尿病患者中的有效性和安全性
机译:IMEGLIMIN单疗法对2型糖尿病患者的安慰剂的疗效和安全性(时间1):双盲,随机,安慰剂控制,并联组,多中心3阶段试验